All Studies

In Silico Analysis Reveals the Inhibitory Potential of Madecassic Acid against Entry Factors of SARS-CoV-2.

Madecassic acid (MDCA) is a natural compound with anti-inflammatory and other medicinal properties. A study investigated its potential as a drug against COVID-19. Computer simulations showed that MDCA could bind to several key proteins involved in the virus' infection process, including the spike protein and its receptors, with high affinity. MDCA also formed strong interactions with these proteins. This suggests that MDCA could be a promising multi-target drug to combat SARS-CoV-2, especially against mutant strains.

Ganguly A et al (2023).
ACS Appl Bio Mater.
PubMed:
36608326

Microwave-assisted and chemically tailored chlorogenic acid-functionalized silver nanoparticles of Citrus sinensis in gel matrix aiding QbD design for the treatment of acne.

Alam A et al (2023).
J Cosmet Dermatol.
PubMed:
36606381